Marrone Bio Innovations’ New Plant Health Product, Pacesetter®, Delivers a Six to One Return on Investment for Corn and So...
February 08 2021 - 9:15AM
Marrone Bio Innovations (MBI) (NASDAQ: MBII),
announced today that its foliar plant health product for row crops,
Pacesetter, showed outstanding performance in 2020 field trials in
the U.S. Midwest. Grower demo trials saw an average of a six-to-one
return on investment with improved yield of 6.4 bushels per acre in
corn and 3.3 bushels per acre in soybeans.
“Growers and distributors are very pleased with
the results they saw from the Pacesetter field trials,” states
Timothy Knight, senior director of North and Central American
sales. “Using Pacesetter to produce healthier, higher-yielding
plants, is an excellent example of how a BioUnite™ approach –
combining biologicals and traditional chemistry – can help growers
achieve the highest return for their crop.”
Pacesetter is recommended for use with
conventional fungicides to increase leaf chlorophyll content and
improve plant health resulting in increased crop yield beyond what
synthetic fungicides alone can generate. Developed for row crops
such as corn, soybeans, cereal grains, cotton and more, Pacesetter
has been shown to improve overall health and crop vigor, resulting
in increased yields and profits.
More than 90 field trials conducted throughout
the Midwest during the 2020 growing season showed Pacesetter, when
combined with a conventional fungicide, out-yielded fungicide use
alone. Average return on investment in the trials was above six to
one and numerous plant health benefits were witnessed. For corn,
longer and wider ear leaf size, increased number of corn kernel
rows, and longer and healthier corn kernels were observed. Soybeans
had healthier plants and more pods per plant.
In the past, MBI’s foliar products have been
focused on specialty crops in the U.S. West and East Coast. With
the introduction of Pacesetter, MBI is now able to reach the vast
corn and soybean acreage of the Midwest – expected to be over 179
million acres in 2021, according to a November 10, 2020 USDA
report. The introduction of the plant health product will provide
growers with a novel solution to improve yield and return on
investment.
Pacesetter is currently available for sale in
the U.S. and is approved for use on corn, soybeans, cereal grain,
cotton and more.
To learn more about Pacesetter, visit
https://marronebio.com/products/pacesetter/.
About Marrone Bio
InnovationsMarrone Bio Innovations Inc. (NASDAQ: MBII) is
a growth-oriented company leading the movement to a more
sustainable world through the discovery, development and sale of
innovative biological products for crop protection and plant health
that help customers operate more sustainably while increasing their
return on investment. MBI has screened over 18,000 microorganisms,
leveraging its in-depth knowledge of plant and soil microbiomes
enhanced by advanced molecular technologies and natural product
chemistry to rapidly develop seven product lines. Supported by a
robust portfolio of over 500 issued and pending patents, MBI’s
currently available commercial products are Regalia®, Stargus®,
Grandevo®, Venerate®, Majestene®, Haven®, Pacesetter®,
Zelto® Jet-Oxide® and Jet-Ag®, with a next-generation
insecticide-nematicide, a breakthrough bioherbicide and a
biofumigant in the Company’s product pipeline. MBI’s Pro Farm
Finland-based subsidiary employs a proprietary technology derived
from wood waste to stimulate plant growth and improve plant health,
resulting in improved yields and crop quality. Products include
UBP™ 110, Foramin®, UBP™ Seed Treatment, Foramin® ST.
Learn more about Marrone Bio
Innovations at www.marronebio.com. We also use our investor
relations website, https://investors.marronebio.com, as well
as our corporate Twitter account, @Marronebio, as means of
disclosing material non-public information, and encourage our
investors and others to monitor and review the information we make
public in these locations. Follow us on social
media: Twitter, LinkedIn and Instagram.
Marrone Bio Innovations
Forward Looking StatementsThis press release contains
forward-looking statements that involve substantial risks and
uncertainties. All statements, other than statements of historical
facts, included in this press release regarding strategy, future
operations and plans, including assumptions underlying such
statements, are forward-looking statements, and should not be
relied upon as representing MBI’s views as of any subsequent date.
Such forward-looking statements are based on information available
to the Company as of the date of this release and involve a number
of risks and uncertainties, some beyond the Company’s control, that
could cause actual results to differ materially from those
anticipated by these forward-looking statements, including, the
sales potential in the U.S. Midwest, weather, the novel coronavirus
COVID-19, regulatory and other factors affecting demand for the
MBI’s products, any difficulty in marketing MBI’s products in its
target markets, competition in the market for pest management
products, lack of understanding of bio-based pest management
products by customers and growers. Additional information that
could lead to material changes in MBI’s performance is contained in
its filings with the SEC. MBI is under no obligation to, and
expressly disclaims any responsibility to, update or alter
forward-looking statements contained in this release, whether as a
result of current information, future events or otherwise.
Marrone Bio Innovations
Contact:Clyde Montevirgen, VP of Business Development
& Investor Relationsinfo@marronebio.com1-530-750-2800
Investor Relations
Contact:Lucas A. ZimmermanSenior Vice PresidentMZ Group –
MZ North AmericaMain: 949-259-4987MBII@mzgroup.us
www.mzgroup.us
Marrone Bio Innovations (NASDAQ:MBII)
Historical Stock Chart
From Mar 2024 to Apr 2024
Marrone Bio Innovations (NASDAQ:MBII)
Historical Stock Chart
From Apr 2023 to Apr 2024